Journey Medical (DERM) Change in Receivables (2020 - 2025)
Historic Change in Receivables for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $2.4 million.
- Journey Medical's Change in Receivables rose 17537.06% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 9823.09%. This contributed to the annual value of -$4.5 million for FY2024, which is 6434.55% up from last year.
- Per Journey Medical's latest filing, its Change in Receivables stood at $2.4 million for Q3 2025, which was up 17537.06% from -$2.8 million recorded in Q2 2025.
- In the past 5 years, Journey Medical's Change in Receivables registered a high of $8.0 million during Q1 2022, and its lowest value of -$10.4 million during Q2 2023.
- Moreover, its 5-year median value for Change in Receivables was -$83000.0 (2022), whereas its average is -$254315.8.
- Data for Journey Medical's Change in Receivables shows a peak YoY increase of 1417058.82% (in 2023) and a maximum YoY decrease of 1053855.42% (in 2023) over the last 5 years.
- Quarter analysis of 5 years shows Journey Medical's Change in Receivables stood at -$8.5 million in 2021, then skyrocketed by 99.4% to -$51000.0 in 2022, then skyrocketed by 14170.59% to $7.2 million in 2023, then tumbled by 110.41% to -$747000.0 in 2024, then soared by 423.29% to $2.4 million in 2025.
- Its Change in Receivables stands at $2.4 million for Q3 2025, versus -$2.8 million for Q2 2025 and $8.0 million for Q1 2025.